| Letter to the Editor From Raven et al:“Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine” LM Raven, AI McCormack, JR Greenfield The Journal of Clinical Endocrinology & Metabolism 107 (4), e1767-e1768, 2022 | 21 | 2022 |
| Delayed gastric emptying with perioperative use of glucagon-like peptide-1 receptor agonists LM Raven, A Stoita, RB Feller, C Brown, JR Greenfield The American Journal of Medicine 136 (12), e233-e234, 2023 | 11 | 2023 |
| SGLT2 Inhibitor–Induced Ketoacidosis in a Patient Without Diabetes AG Hayes, LM Raven, A Viardot, E Kotlyar, JR Greenfield Diabetes Care 47 (1), e4-e5, 2024 | 10 | 2024 |
| Sodium glucose cotransporter 2 inhibitor‐induced ketoacidosis is unlikely in patients without diabetes LM Raven, CA Muir, JR Greenfield Medical Journal of Australia 219 (7), 293-294, 2023 | 8 | 2023 |
| Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment LM Raven, M Guttman-Jones, CA Muir Endocrine 72, 524-528, 2021 | 6 | 2021 |
| Female representation: Australian diabetes and endocrinology societies LM Raven, AI McCormack Frontiers in Endocrinology, 303, 2022 | 5 | 2022 |
| Medical student views about changes to internships in South Australia TD Crowhurst, J Floridis, LM Raven The Medical Journal of Australia 197 (2), 90-91, 2012 | 5 | 2012 |
| Considerations of delayed gastric emptying with peri‐operative use of glucagon‐like peptide‐1 receptor agonists LM Raven, C Brown, JR Greenfield Medical Journal of Australia 220 (1), 14-16, 2024 | 4 | 2024 |
| Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a … LM Raven, CA Muir, CK Iglesias, NK Bart, K Muthiah, E Kotlyar, ... BMJ Open 13 (3), e069641, 2023 | 3 | 2023 |
| Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices S Chavali, S Barua, A Adji, D Robson, LM Raven, JR Greenfield, ... International Journal of Cardiology 391, 131259, 2023 | 2 | 2023 |
| Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies—a joint review from endocrinologists and cardiologists LM Raven, CA Muir, PS Macdonald, CS Hayward, A Jabbour, ... Acta Diabetologica 60 (4), 471-480, 2023 | 2 | 2023 |
| Glucagon-like peptide-1 receptor agonist treatment with semaglutide in type 1 diabetes LM Raven, JR Greenfield, CA Muir JCEM Case Reports 1 (1), luac017, 2023 | 2 | 2023 |
| Obesity Assessment and Management Using an Illustrative Case in Severe Mental Illness LM Raven, K Samaras A Case-Based Guide to Clinical Endocrinology, 451-459, 2022 | 2 | 2022 |
| Understanding the cardiovascular benefits of glucagon-like peptide-1 (GLP-1) receptor agonists LM Raven Trends in cardiovascular medicine, S1050-1738 (24) 00030-6, 2024 | 1 | 2024 |
| Metabolic sequelae of everolimus treatment after cardiac transplant: a hypothesis-generating study LM Raven, CA Muir, J Pouliopoulos, CS Hayward, PS Macdonald, ... Heart, Lung and Circulation 32 (9), 1076-1079, 2023 | 1 | 2023 |
| Fournier’s gangrene in recent transplant recipient on empagliflozin LM Raven, JY Cao, PS Macdonald, A Jabbour, JR Greenfield JHLT Open 4, 2024 | | 2024 |
| Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation LM Raven, CA Muir, RC Deveza, CK Iglesias, NK Bart, K Muthiah, ... JHLT Open, 100088, 2024 | | 2024 |
| Safety of Sodium Glucose Co-Transporter 2 Inhibitor Exposure Prior to Heart Transplantation LM Raven, CA Muir, CK Iglesias, NK Bart, K Muthiah, E Kotlyar, ... The Journal of Heart and Lung Transplantation 43 (4), S148-S149, 2024 | | 2024 |
| Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in End-Stage Heart Failure Patients Considered for Heart Transplantation S Jeyakumar, R Jeyakumar, D Robson, L Honeysett, L Raven, ... The Journal of Heart and Lung Transplantation 43 (4), S106, 2024 | | 2024 |
| Early post-transplant hyperglycemia and post-transplant diabetes mellitus following heart transplantation W Kuang, LM Raven, CA Muir Expert Review of Endocrinology & Metabolism 19 (2), 129-140, 2024 | | 2024 |
